全文获取类型
收费全文 | 69734篇 |
免费 | 3679篇 |
国内免费 | 1112篇 |
专业分类
耳鼻咽喉 | 273篇 |
儿科学 | 1617篇 |
妇产科学 | 934篇 |
基础医学 | 8142篇 |
口腔科学 | 1831篇 |
临床医学 | 4961篇 |
内科学 | 15992篇 |
皮肤病学 | 691篇 |
神经病学 | 5208篇 |
特种医学 | 1305篇 |
外国民族医学 | 4篇 |
外科学 | 8820篇 |
综合类 | 5154篇 |
现状与发展 | 7篇 |
一般理论 | 3篇 |
预防医学 | 6395篇 |
眼科学 | 705篇 |
药学 | 7258篇 |
32篇 | |
中国医学 | 3080篇 |
肿瘤学 | 2113篇 |
出版年
2023年 | 1173篇 |
2022年 | 1547篇 |
2021年 | 2889篇 |
2020年 | 2209篇 |
2019年 | 4181篇 |
2018年 | 3461篇 |
2017年 | 2645篇 |
2016年 | 1728篇 |
2015年 | 1707篇 |
2014年 | 3133篇 |
2013年 | 3449篇 |
2012年 | 2739篇 |
2011年 | 3026篇 |
2010年 | 2338篇 |
2009年 | 2315篇 |
2008年 | 2293篇 |
2007年 | 2057篇 |
2006年 | 1734篇 |
2005年 | 1506篇 |
2004年 | 1247篇 |
2003年 | 1049篇 |
2002年 | 789篇 |
2001年 | 646篇 |
2000年 | 582篇 |
1999年 | 528篇 |
1998年 | 525篇 |
1997年 | 530篇 |
1996年 | 459篇 |
1995年 | 442篇 |
1994年 | 427篇 |
1993年 | 376篇 |
1992年 | 325篇 |
1991年 | 319篇 |
1990年 | 256篇 |
1989年 | 260篇 |
1988年 | 205篇 |
1987年 | 188篇 |
1985年 | 1628篇 |
1984年 | 2649篇 |
1983年 | 2427篇 |
1982年 | 1835篇 |
1981年 | 1890篇 |
1980年 | 1598篇 |
1979年 | 1364篇 |
1978年 | 1166篇 |
1977年 | 683篇 |
1976年 | 1118篇 |
1975年 | 979篇 |
1974年 | 812篇 |
1973年 | 785篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献52.
53.
54.
Sharisse M. Arnold Rehring Liza M. Reifler Jennifer H. Seidel Karen A. Glenn John F. Steiner 《Academic pediatrics》2019,19(5):572-580
ObjectiveClinical specialty societies recommend long-acting reversible contraceptives (LARCs) as first-line contraception for adolescent women. We evaluated whether a combined educational and process improvement intervention enhanced LARC placement in primary care within an integrated health care system.MethodsThe intervention included journal clubs, live continuing education, point-of-care guidelines, and new patient materials. We conducted a retrospective cohort study across 3 time periods: baseline (January 2013?September 2015), early implementation (October 2015–March 2016), and full implementation (April 2016–June 2017). The primary outcome was the proportion of LARCs placed by primary care clinicians among women aged 13 to 18 years compared with gynecology clinicians.ResultsKaiser Foundation Health Plan of Colorado cared for approximately 20,000 women aged 13 to 18 years in each calendar quarter between 2013 and 2017. Overall, LARC placement increased from 7.0 per 1000 members per quarter at baseline to 13.0 per 1000 during the full intervention. Primary care clinicians placed 6.2% of all LARCs in 2013, increasing to 32.1% by 2017 (P < .001), including 45.5% of contraceptive implants. Clinicians who attended educational sessions were more likely to adopt LARCs than those who did not (17.9% vs 6.4% respectively, P = .009). Neither overall LARC placement rates (relative risk, 1.9; 95% confidence interval, 0.7?5.6) nor contraceptive implant rates (relative risk, 3.0; 95% confidence interval, 0.9?9.8) increased significantly in clinicians who attended educational activities.ConclusionsThis multimodal intervention was associated with increased LARC placement for adolescent women in primary care. The combination of education and process improvement is a promising strategy to promote clinician behavior change. 相似文献
55.
《Clinical neurophysiology》2019,130(9):1562-1569
ObjectiveConventional deep brain stimulation (DBS) systems with ring-shaped leads generate spherical electrical fields. In contrast, novel directional leads use segmented electrodes. Aim of this study was to quantify the impedance variations over time in subjects with the directional Cartesia-Boston® system.MethodsImpedance records, programming settings, and clinical data of 11 consecutive Parkinsonian patients implanted with DBS directional leads in two Italian centers (Udine and Vicenza) were retrospectively evaluated. Data were collected before starting stimulation (in the operating room and at days 5 and 40) and after switching stimulation on at the successive follow-up visits (1, 6 and 12 months).ResultsDirectional leads have significantly higher impedance than ring leads. Stimulated contacts had always lower impedance compared to non-stimulated contacts. Before DBS-on, all contacts had higher impedance in the operating room, with an initial decrease five days post-surgery and a subsequent increase at day 40, more evident for directional contacts. The impedance of directional leads increased post-implantation at 1 and 6 months with a plateau at 12 months.ConclusionsThere was a significant difference between the directional and ring leads at baseline (before activation of DBS) and during follow-up (chronic DBS).SignificanceOur study reveals new information about the impedance of segmented electrodes that is useful for patient management during the initial test period, as well as during long-term DBS follow-up. 相似文献
56.
57.
58.
59.
《Heart, lung & circulation》2019,28(10):1463-1471
60.